Response of cerebral metastasis secondary to prostate cancer to primary androgen suppression.
We report the case of an 80-year-old man who presented with relapsing prostate cancer and cerebral metastases which showed evidence of radiological and clinical response to androgen suppression alone without additional whole brain radiotherapy.
Department of Clinical Oncology, Mount Vernon Cancer Centre, Northwood, UK. neel.bhuva@gmail.com
N J
NJ
Bhuva
D
D
Ward
R
R
Hughes
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary*; D000369:Aged, 80 and over; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D018450:Disease Progression; D017273:Goserelin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D060787:Neoplasm Grading; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000473:pathology; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014057:Tomography, X-Ray Computed; D020728:Transurethral Resection of Prostate
D018931:Antineoplastic Agents, Hormonal; D017273:Goserelin